Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares (CANF) earnings
Quarterly and annual CANF reports and results, each read against the price at its own news timestamp. Back to the CANF overview →
1 measured CANF earnings event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Can-Fite Reports Third Quarter 2023 Financial Results and Clinical Update | Press release | +5.38% | +5.38% |
Keep exploring
More CANF: analyst actions → · SEC filings → · CANF overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | 279 | -0.52% | 36% |
| CORREVIO PHARMA CORP ORDINARY SHARES (CORV) | 279 | 0.00% | 44% |
| AtriCure, Inc. (ATRC) | 276 | +0.04% | 51% |
| Coherus Oncology, Inc. (CHRS) | 276 | +0.21% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.